Therapy and Rehabilitation – Page 10

To Prepare for Psychedelic Therapy, Doctors Breathe Their Way to an Altered State

As psychedelics move from the underground to mainstream medicine, clinicians aspiring to work in the field are inducing altered states with deep breathing.

By Ernesto Londono

Blood Bone Marrow Crispr (DNA) Developing Countries Drugs (Pharmaceuticals) Food and Drug Administration Genetic Engineering Genetics and Heredity Income Inequality Sickle Cell Anemia Stem Cells Therapy and Rehabilitation Transplants Vertex Pharmaceuticals Inc

New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most

There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.

By Rebecca Robbins and Stephanie Nolen

Crispr (DNA) CRISPR Therapeutics Drugs (Pharmaceuticals) Food and Drug Administration Genetic Engineering Sickle Cell Anemia Therapy and Rehabilitation Vertex Pharmaceuticals Inc

F.D.A. Experts Will Vote on a Cure for Sickle Cell Disease

The treatment from the company Vertex would be the first medicine to use the gene editing tool CRISPR.

By Gina Kolata

Drug Enforcement Administration Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration MAPS Public Benefit Corporation Post-Traumatic Stress Disorder Psychiatry and Psychiatrists Research Therapy and Rehabilitation

MDMA Therapy for PTSD Inches Closer to U.S. Approval

Results of a new study may offer regulators enough evidence to allow the psychedelic, also known as Ecstasy, to be considered for use as a PTSD treatment.

By Rachel Nuwer